Direct Answer
IFRS vs. US GAAP differences that matter most to cross-border equity analysis are inventory costing (LIFO is allowed under US GAAP but banned under IFRS), R&D capitalization (IFRS permits capitalizing qualifying development costs, US GAAP generally requires expensing R&D), lease accounting mechanics, and statement presentation conventions. Revenue recognition, once a major divide, is now largely converged under ASC 606 and IFRS 15. The core discipline is checking whether the specific line item being compared is actually measured the same way before drawing a conclusion from the raw numbers.
Key Takeaways
- LIFO inventory costing is permitted under US GAAP but prohibited under IFRS, which can distort a direct COGS, gross margin, or inventory turnover comparison in inflationary periods.
- IFRS permits (and in qualifying cases requires) capitalizing development costs once specific feasibility criteria are met, while US GAAP generally expenses R&D immediately - this can shift near-term earnings and asset bases between otherwise-similar companies.
- Revenue recognition is largely converged under ASC 606 (US GAAP) and IFRS 15 - treat this as a mostly-resolved historical difference rather than a live comparison risk.
- Both frameworks now require most leases on-balance-sheet (ASC 842 / IFRS 16), though some classification and expense-presentation mechanics still differ between them.
- IFRS statements sometimes use different line-item labels and a different statement ordering than US GAAP filings - a practical read-the-filing caveat independent of any accounting-policy difference.
- Before comparing any specific metric across a US GAAP and an IFRS filer, confirm the underlying line item is measured the same way in both - don't assume comparability from a shared label.
Why Is LIFO Inventory a Comparability Problem?
US GAAP permits companies to choose among several inventory costing methods, including last-in-first-out (LIFO), first-in-first-out (FIFO), and weighted-average cost. IFRS prohibits LIFO outright - IFRS-reporting companies must use FIFO, weighted-average cost, or specific identification.
The gap matters most during inflationary periods. A LIFO company matches its most recently purchased (typically higher-cost) inventory against current revenue, which pushes reported cost of goods sold higher and reported inventory value lower relative to an otherwise-identical FIFO company. That means a US company using LIFO can show a lower gross margin and a lower inventory balance than an IFRS peer with genuinely similar underlying operations and input costs - the gap is a costing-method artifact, not a sign of weaker unit economics.
What to check: US GAAP filers using LIFO are required to disclose a LIFO reserve - the difference between LIFO-based and FIFO-based inventory values - typically in the inventory footnote. Adding that reserve back to reported inventory (and adjusting COGS accordingly) puts a LIFO filer on a roughly FIFO-equivalent basis before comparing it to an IFRS peer.
How Does R&D Capitalization Differ?
US GAAP (ASC 730) generally requires research and development costs to be expensed as incurred, with limited exceptions. IFRS (IAS 38) draws a sharper line between the two halves of "R&D": research costs must be expensed, but development costs - work past the research stage, closer to a commercially viable product or process - can, and in qualifying cases must, be capitalized once the company can demonstrate specific technical and commercial feasibility criteria (including technical feasibility, intent and ability to complete the asset, ability to use or sell it, and reliable cost measurement).
The practical effect: two companies spending an economically similar amount on R&D can report meaningfully different near-term earnings and balance sheets purely because of where each falls under its accounting framework. The IFRS company capitalizing development spend shows a smaller current-period expense hit (and a larger intangible asset base, amortized over future periods) than the US GAAP company expensing the equivalent spend immediately. Neither treatment is "wrong" - they reflect different rules, not different economics - but comparing R&D-to-revenue ratios or operating margins across the two without adjustment can overstate the IFRS company's near-term profitability advantage.
What to check: Look for a breakout of capitalized development costs in the intangible assets footnote of an IFRS filer, and consider normalizing by adding capitalized development spend back into the expense base (and removing the related amortization) when comparing margins directly to a US GAAP peer.
Is Revenue Recognition Still a Major Difference?
Largely, no - and this is worth stating plainly rather than overstating a gap that mostly no longer exists. ASC 606 (US GAAP) and IFRS 15 converged the core revenue recognition model around a shared five-step framework: identify the contract, identify performance obligations, determine the transaction price, allocate the price to performance obligations, and recognize revenue as obligations are satisfied. The two standards were developed jointly with the explicit goal of eliminating the older, more fragmented revenue rules that used to differ significantly between frameworks.
Remaining differences tend to be narrower interpretation and disclosure points in specific situations rather than a broad structural divide. For most cross-border comparisons today, revenue recognition should not be the first place to look for a comparability gap - inventory costing, R&D treatment, and lease mechanics are more likely to matter.
What About Lease Accounting?
Both frameworks moved to put most leases on the balance sheet: ASC 842 under US GAAP and IFRS 16 under IFRS. Before these standards, operating leases could largely stay off-balance-sheet, which understated liabilities for lease-heavy businesses like retailers and airlines under both frameworks' older rules.
The two current standards aren't identical in their mechanics. In broad terms, IFRS 16 treats nearly all leases with a single on-balance-sheet model, while US GAAP's ASC 842 retains more of a distinction in expense presentation between finance leases and operating leases (both go on the balance sheet, but they can flow through the income statement somewhat differently). The precise classification tests and expense-timing effects are detailed and can matter for specific companies - if lease-heavy operations are central to a comparison, that's worth a closer look at each company's leases footnote rather than assuming the balance-sheet totals are built the same way.
Presentation and Format Differences
Beyond the accounting-policy differences above, IFRS and US GAAP filings can simply look different on the page. IFRS statements sometimes order the balance sheet with non-current items first (the reverse of the common US GAAP convention of current items first), use different line-item labels for economically similar items, and present certain subtotals (like "profit for the period" vs. "net income") under different naming conventions.
This is a practical read-the-filing caveat, not a substantive accounting difference - but it matters in practice because a line-by-line comparison built on matching labels rather than matching definitions can silently misalign two statements that are actually measuring the same thing, or fail to notice that two similarly-labeled lines are not measuring the same thing at all.
IFRS vs. US GAAP: Quick Comparison
| Area | US GAAP | IFRS | Why it matters to analysis |
|---|---|---|---|
| Inventory costing | LIFO permitted (also FIFO, weighted-average) | LIFO prohibited (FIFO, weighted-average, specific identification only) | Distorts COGS/margin/inventory comparisons in inflationary periods unless adjusted via LIFO reserve. |
| R&D | Generally expensed as incurred | Research expensed; qualifying development costs capitalized | Can shift near-term earnings and asset bases between similar-spending companies. |
| Revenue recognition | ASC 606 | IFRS 15 | Largely converged - a mostly-resolved historical difference, not a major live risk. |
| Leases | ASC 842 - most leases on-balance-sheet, finance/operating expense presentation differs | IFRS 16 - most leases on-balance-sheet under a more unified model | Both improved comparability over pre-reform rules; some classification/expense mechanics still differ. |
| Statement format | Common convention: current items first on balance sheet | Common convention: non-current items first; different line-item labels | A practical caveat when matching line items across filings - check definitions, not just labels. |
This table is a starting map, not a substitute for reading each company's own accounting-policy footnotes - specific companies can apply elections, transition rules, or industry-specific guidance that shift the general pattern.
The Research Discipline: Check the Line Item, Not the Label
The overarching habit that matters more than memorizing every rule difference: before comparing a specific line item - R&D expense, inventory turnover, gross margin, lease expense - between a US GAAP company and an IFRS peer, check whether that item is actually measured the same way under each framework. A shared label does not guarantee a shared definition.
- Read the "basis of preparation" or "significant accounting policies" footnote in both filings before comparing any ratio built from inventory, R&D, leases, or intangibles.
- Look for a company's own reconciliation or non-GAAP adjustment if one is provided - management sometimes flags a framework-driven distortion explicitly.
- When no adjustment is available, treat the raw comparison as directional rather than precise, and note which specific line items are most likely affected.
- Remember that a real business-quality or valuation difference can still exist alongside an accounting-framework difference - the goal is separating the two, not assuming the accounting explains everything.
Risks and Limitations
Accounting standards evolve, and both IFRS and US GAAP issue amendments, industry-specific guidance, and transition provisions that can shift the general patterns described here for a specific company or period. This page intentionally covers a handful of the highest-impact differences for equity research rather than attempting an exhaustive technical accounting comparison - company-specific elections, first-time adoption effects, and jurisdiction-specific carve-outs can all matter for a particular filing. Always confirm the applicable standard and any recent amendments in the company's own accounting-policy footnotes rather than relying on a general framework summary alone.
Frequently Asked Questions
What differences between IFRS and U.S. GAAP matter to cross-border analysis?
The highest-impact differences for an equity analyst are inventory costing (LIFO is allowed under US GAAP but prohibited under IFRS), R&D capitalization (IFRS permits capitalizing qualifying development costs while US GAAP generally requires expensing R&D immediately), lease accounting mechanics, and statement presentation/format conventions. Revenue recognition is now largely converged between the two frameworks and is less of a live difference than it used to be.
Why does LIFO matter when comparing a US company to an IFRS peer?
LIFO (last-in, first-out) inventory costing is permitted under US GAAP but prohibited under IFRS. A US company using LIFO during inflationary periods reports higher cost of goods sold and lower reported inventory value than an otherwise-identical IFRS peer using FIFO or weighted-average costing, which distorts a direct gross margin or inventory turnover comparison unless adjusted for.
How does R&D capitalization differ between IFRS and US GAAP?
US GAAP generally requires companies to expense research and development costs as incurred. IFRS distinguishes research from development: research costs are expensed, but development costs can, and in some cases must, be capitalized once specific technical and commercial feasibility criteria are met. This can make an IFRS company's near-term reported earnings and balance sheet look different from a US GAAP peer with genuinely similar underlying R&D spending.
Is revenue recognition still a major IFRS vs. US GAAP difference?
Not to the degree it once was. ASC 606 (US GAAP) and IFRS 15 largely converged the core revenue recognition model around a shared five-step framework. Differences that remain tend to be narrower, situation-specific interpretation and disclosure points rather than a broad structural gap - it's more accurate to note the convergence than to treat revenue recognition as a major ongoing divide.
Should I trust a raw cross-border metric comparison without adjustment?
Not without checking whether the specific line items being compared are measured the same way. Confirm the inventory costing method, whether R&D or other intangible spending is expensed or capitalized, how leases are classified and presented, and how each company labels and orders its statement line items before drawing a conclusion from the raw reported numbers.
Related Reading
- International & Currency Analysis - the parent hub for cross-border fundamental research.
- ADRs vs. Ordinary Shares - sponsored foreign private issuers often file IFRS financials with the SEC, making the framework difference directly relevant when researching an ADR.
- Financial Footnotes & Accounting Policies - where a company's specific inventory costing, R&D, and lease policy elections are actually disclosed.
- Fundamental Analysis: How to Analyze a Stock Step by Step - the full pillar guide this page is part of.